{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "PharmaEssentia Innovation Research Center (PIRC), Bedford, MA, USA",
    "Paediatric Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK",
    "Inflammation and Immunology, Pfizer Research, 200 CambridgePark Drive, Cambridge, UK",
    "PharmaEssentia Innovation Research Center, Bedford, MA, USA",
    "PharmaEssentia Corporation, Taipei, Taiwan"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 20,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Kuan-Chun Huang"
    },
    {
      "affs": [
        1
      ],
      "name": "Robert Wheeler"
    },
    {
      "affs": [
        2
      ],
      "name": "Lih-Ling Lin"
    },
    {
      "affs": [
        3
      ],
      "name": "Celesztina Nagy-Domonkos"
    },
    {
      "affs": [
        0
      ],
      "name": "Ali Sepahi"
    },
    {
      "affs": [
        0
      ],
      "name": "Molly Foster"
    },
    {
      "affs": [
        0
      ],
      "name": "Kelsey Joyce"
    },
    {
      "affs": [
        0
      ],
      "name": "Henry S Cheng"
    },
    {
      "affs": [
        0
      ],
      "name": "Mei-Ling Yang"
    },
    {
      "affs": [
        3
      ],
      "name": "Jack D Huck"
    },
    {
      "affs": [
        0
      ],
      "name": "Pratiksha Ramteke"
    },
    {
      "affs": [
        0
      ],
      "name": "Ming-Tang Chen"
    },
    {
      "affs": [
        0
      ],
      "name": "Tom Lin"
    },
    {
      "affs": [
        0
      ],
      "name": "Erik R Sampson"
    },
    {
      "affs": [
        4
      ],
      "name": "Menqrong Wu"
    },
    {
      "affs": [
        4
      ],
      "name": "Luke Lin"
    },
    {
      "affs": [
        4
      ],
      "name": "Yite Yo"
    },
    {
      "affs": [
        3
      ],
      "name": "Josephine Orrick"
    },
    {
      "affs": [
        3
      ],
      "name": "Prasanna Baskar"
    },
    {
      "affs": [
        4
      ],
      "name": "Shihlong Yan"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/eqy7hkvk8qgqk.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0897",
  "fulltext_url": null,
  "id": "eqy7hkvk8qgqk",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0897",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ],
    [
      "openalex",
      "2730|Cancer Immunotherapy and Biomarkers"
    ]
  ],
  "openalex": "W7225203751",
  "pdf_url": "https://jitc.bmj.com/content/14/Suppl_2/A1016.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-07",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/eqy7hkvk8qgqk.ris",
  "sources": [
    {
      "first_seen": "2026-11-08T14:20:41Z",
      "native_id": "0670bda74f7243189675aa7daa4e023c",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0897"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|Cancer Immunotherapy and Biomarkers",
      "subfield": "oncology"
    }
  ],
  "title": "897 Pre-clinical characterization of PEC3001, a PD-1 targeted IL-2Rα-active IL-2 immunocytokine with potent anti-tumor activity and a favorable safety profile",
  "title_text": "897 Pre-clinical characterization of PEC3001, a PD-1 targeted IL-2Rα-active IL-2 immunocytokine with potent anti-tumor activity and a favorable safety profile",
  "type": "peer-reviewed",
  "updated_at": "2026-11-09T14:21:01Z",
  "url": "https://research.draconitic.com/paper/eqy7hkvk8qgqk",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}